The present study aimed to assess the diagnostic performance of ultrasound-guided endobronchial intra-nodal miniforceps biopsy (EBUS-MFB) in the diagnosis of "de novo" mediastinal lymphoma.
Every patients will be sampled using both EBUS-MFB and the standard of care EBUS-TBNA (transbronchial needle aspiration). It is a monocentric investigation. Pathologist will not know the way of sampling while analysing the samples
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
33
Mediastinal node is sampled using three path of classic ultrasound guided transbronchial needle aspiration (EBUS-TBNA). A reduce size forceps is then inserted inside the mediastinal node via the duc EBUS-TBNA made and biopsies (EBUS-MFB) are made using real time ultrasound guidance.
CaenUH
Caen, Normandy, France
RECRUITINGpositivity of the procedure in Diagnosis and Subtyping of lymphoma
a sample wil be considered positive if it allows the clinical management of the patient, without additional sampling required.
Time frame: up to 3 years
every adverse effect related to the procedure
infectious process related to the procedure, hemoptysis over 50cc, worsening of respiratory status requiring hospitalization
Time frame: up to 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.